Personalized supplements for high homocysteine and cholesterol
Part of Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study tests a personalized approach based on your genes to choose the right natural supplements for people with high homocysteine and high LDL cholesterol. It aims to help lower these levels safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your blood test shows homocysteine levels above 15 µmol/L.
- Your LDL cholesterol is at least 1.4 mmol/L.
- You haven't taken any medications or supplements that affect homocysteine for at least 1 month.
- You are not pregnant or breastfeeding.
- You don't have a severe illness that would require constant monitoring (expected survival less than 1 year).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a substance in your blood called homocysteine and how it affects the early filling of your heart's main pumping chamber. It may help doctors understand heart risks in people newly diagnosed with high blood pressure.
This study tests two dietary supplements to see if they can improve cholesterol levels in people with mildly high cholesterol who are otherwise healthy and at low risk for heart disease.
This trial tests a one-time gene therapy (NGGT006) to treat a severe form of inherited high cholesterol that doesn't respond well to standard medications. It aims to lower cholesterol and reduce the risk of heart disease.
This trial tests whether two different food supplements can improve cholesterol levels in people with mild high cholesterol. It aims to find a safe and natural way to help manage cholesterol without medication.
This trial tests whether a study medicine regimen can help prevent a first stroke in people with hard-to-control “high homocysteine” risk factors linked to a specific gene type. You may qualify if you have certain blood pressure levels, a specific MTHFR gene result, and related blood test findings.
This trial tests a new investigational medicine (SYH2053) for people with high cholesterol or mixed hyperlipidemia who are already on cholesterol-lowering therapy but still have high levels of 'bad cholesterol' (LDL-C). The goal is to see if this add-on treatment can help lower cholesterol further and reduce heart disease risk.
Hear when a new Hyperhomocysteinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.